SEPARATION AGREEMENT AND GENERAL RELEASESeparation Agreement and General Release • May 10th, 2017 • Galena Biopharma, Inc. • Pharmaceutical preparations • California
This Separation Agreement and General Release (this "Agreement") is hereby entered into by and between Mark W. Schwartz, Ph.D., an individual (the "Employee"), and Galena Biopharma, Inc., on behalf of itself and all of its affiliated entities, specifically including Apthera, Inc. and Mills Pharmaceuticals, LLC (collectively, the "Company").
February 23, 2017 Stephen Ghiglieri [Address] Dear Mr. Ghiglieri:Galena Biopharma, Inc. • May 10th, 2017 • Pharmaceutical preparations
This Retention Agreement establishes the terms of the retention payment during your continued employment with Galena Biopharma, Inc. (“Galena” or “Company”), as the Company seeks to pursue strategic alternatives for the Company.
February 23, 2017 Bijan Nejadnik, M.D. [Address] Dear Dr. Nejadnik:Retention Agreement • May 10th, 2017 • Galena Biopharma, Inc. • Pharmaceutical preparations
This Retention Agreement establishes the terms of the retention payment during your continued employment with Galena Biopharma, Inc. (“Galena” or “Company”), as the Company seeks to pursue strategic alternatives for the Company.
February 23, 2017 John Burns [Address] Dear Mr. Burns:Galena Biopharma, Inc. • May 10th, 2017 • Pharmaceutical preparations
This Retention Agreement establishes the terms of the retention payment during your continued employment with Galena Biopharma, Inc. (“Galena” or “Company”), as the Company seeks to pursue strategic alternatives for the Company.
February 23, 2017 Thomas J. Knapp [Address] Dear Mr. Knapp:Galena Biopharma, Inc. • May 10th, 2017 • Pharmaceutical preparations
This Retention Agreement establishes the terms of the retention payment during your continued employment with Galena Biopharma, Inc. (“Galena” or “Company”), as the Company seeks to pursue strategic alternatives for the Company.
